Susquehanna International Group’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $12.9K | Buy |
|
|||||
|
2024
Q3 | $20.9K | Sell |
|
|||||
|
2024
Q2 | $222K | Buy |
|
|||||
|
2024
Q1 | $254K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $49.2K | Sell |
|
|||||
|
2023
Q2 | $1.67M | Buy |
|
|||||
|
2023
Q1 | $1.16M | Buy |
|
|||||
|
2022
Q4 | $435K | Sell |
|
|||||
|
2022
Q3 | $616K | Sell |
|
|||||
|
2022
Q2 | $1.05M | Sell |
|
|||||
|
2022
Q1 | $2.6M | Sell |
|
|||||
|
2021
Q4 | $3.62M | Sell |
|
|||||
|
2021
Q3 | $7.26M | Buy |
|
|||||
|
2021
Q2 | $6.24M | Buy |
|
|||||
|
2021
Q1 | $8.21M | Buy |
|
|||||
|
2020
Q4 | $7.05M | Sell |
|
|||||
|
2020
Q3 | $9.99M | Buy |
|
|||||
|
2020
Q2 | $206K | Buy |
|
|||||
|
2020
Q1 | – | Hold |
|